Exceptional Support for an Unprecedented Opportunity
As part of the American Recovery and Reinvestment Act of 2009, the NIH invites Challenge Grant (RC1) applications from domestic institutions/organizations proposing research on Challenge Topics that address specific scientific and health research challenges in biomedical and behaviorial research that will benefit from significant two-year jumpstart funds. Challenge Areas, defined by the NIH, focus on specific knowlege gaps, scientific opportunities, new technologies, data generation, or research methods that would benefit from an influx of funds to quickly advance the area in significant ways. The research in these areas should have a high impact on biomedical, behavioral science and/or public health.
What type of research qualifies for the stimulus grants?
We've put together an Overview of Sequenom Applications to help you get started, and a listing of the individual topics can be found below:
- Biomarkers
- Epigenetics
- Oncology
- Microbial
- Genome-wide Association Studies (GWAS)
- Oncology
- Stem Cells
- Copy Number Variation (CNV)
- ADMET
- Personalized & Translational Medicine
We're here to help!
Resources to help you get started are listed below, and feel free to contact us if you'd like to know more about Sequenom or need help writing your grant. We can offer you more information on our technology, and even help with letters of support for your grant.
Need ideas?
Get relevant examples of Sequenom technologies being utilized in peer-reviewed publications by searching for your area of interest:
Note: The MassARRAY platform, OncoCarta, iPLEX, iSEQ, EpiTYPER and MelaCarta are for Research Use Only. Not for use in diagnostic procedures. |